AGP Executive Report
Last update: 10 hours agoCancer Care Innovation: A new “smart” tablet (GRWD5769) combined with immunotherapy (cemiplimab) showed tumour shrinkage in early trials, including patients across several cancers after immunotherapy failed. AI in Medicine: A large skin-lesion AI foundation model still lagged the best-performing dermatologists, reinforcing AI as support rather than a replacement in real-world diagnosis. Mental Health Access: France is pushing faster youth mental-health care, aiming to guarantee at-risk support within days. Healthcare Tech in France: RaySearch will showcase advances in particle therapy planning for reirradiation at PTCOG 64 in Deauville, highlighting better dose accumulation evaluation. Pharma & Regulation: CinnaGen became the first Iranian company to get EU approval for an osteoporosis medicine (teriparatide/Zandoriah). Public Health & Safety: FIFA banned refillable water bottles at World Cup matches citing injury risk, amid heat and hydration concerns.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
